In accordance with the declared goal to establish the best available care for patients on dialysis, Fresenius Medical Care appreciates the crucial partnership with the leading biotechnology company AMGEN. The cooperation (established in 2007) between AMGEN and Fresenius Medical Care has brought two leading international partners together in a spirit of sharing expertise in the field of anaemia management. The cooperation enables the optimisation of resources and treatment to provide high quality of care to more and more dialysis patients worldwide.
The most recent partnership was signed in July 2008, bringing together Fresenius Medical Care and Vifor, the Swiss manufacturer of the leading international brand for i.v. iron substitution. By joining interests and sharing experiences, both partners are able to create synergies in order to improve anaemia therapy for dialysis patients. The cooperation is an important milestone for Fresenius Medical Care as we follow our commitment to build a comprehensive portfolio of renal pharmaceuticals.